Olema Pharmaceuticals (OLMA) Short Interest Ratio & Short Volume → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free OLMA Stock Alerts $9.87 -0.06 (-0.60%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Olema Pharmaceuticals Short Interest DataCurrent Short Volume8,100,000 sharesPrevious Short Volume5,060,000 sharesChange Vs. Previous Month+60.08%Dollar Volume Sold Short$91.69 millionShort Interest Ratio / Days to Cover9.9Last Record DateMarch 31, 2024Outstanding Shares55,920,000 sharesPercentage of Shares Shorted14.48%Today's Trading Volume683,166 sharesAverage Trading Volume618,441 sharesToday's Volume Vs. Average110% Short Selling Olema Pharmaceuticals ? Sign up to receive the latest short interest report for Olema Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOLMA Short Interest Over TimeOLMA Days to Cover Over TimeOLMA Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Olema Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20248,100,000 shares $91.69 million +60.1%N/A9.9 $11.32 3/15/20245,060,000 shares $58.44 million +3.9%N/A6.4 $11.55 2/29/20244,870,000 shares $60.39 million -21.2%N/A5.9 $12.40 2/15/20246,180,000 shares $91.53 million -7.9%N/A6.8 $14.81 1/31/20246,710,000 shares $87.50 million -5.2%N/A7.5 $13.04 1/15/20247,080,000 shares $82.13 million +0.7%N/A8.3 $11.60 Get the Latest News and Ratings for OLMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20237,030,000 shares $98.63 million +5.7%N/A8.5 $14.03 12/15/20236,650,000 shares $81.13 million +27.6%N/A8.5 $12.20 11/30/20235,210,000 shares $72.68 million +88.8%N/A8.1 $13.95 11/15/20232,760,000 shares $46.42 million No ChangeN/A6.4 $16.82 10/31/20232,760,000 shares $36.68 million +26.0%7.3%7.9 $13.29 10/15/20232,190,000 shares $27.66 million +10.6%5.8%7.6 $12.63 9/30/20231,980,000 shares $24.45 million +12.5%5.4%7.1 $12.35 9/15/20231,760,000 shares $22.69 million +10.7%4.8%5.9 $12.89 8/31/20231,590,000 shares $16.14 million -9.7%4.4%4.1 $10.15 8/15/20231,760,000 shares $19.03 million -4.4%5.0%4.8 $10.81 7/31/20231,840,000 shares $15.92 million -4.7%5.3%5.1 $8.65 7/15/20231,930,000 shares $15.81 million +5.5%5.6%5.4 $8.19 6/30/20231,830,000 shares $16.52 million +55.1%5.3%5 $9.03 6/15/20231,180,000 shares $10.71 million +14.6%3.4%3.7 $9.08 5/31/20231,030,000 shares $5.33 million No Change3.0%5.2 $5.17 5/15/20231,030,000 shares $6.89 million +1.0%3.0%6.2 $6.69 4/30/20231,020,000 shares $4.89 million -6.4%3.0%6 $4.79 4/15/20231,090,000 shares $3.99 million -4.4%3.2%6.5 $3.66 3/31/20231,140,000 shares $3.96 million +3.6%3.3%6.3 $3.47 3/15/20231,100,000 shares $4.38 million -1.8%3.2%7.5 $3.98 2/28/20231,120,000 shares $4.59 million -21.1%3.3%7.5 $4.10 2/15/20231,420,000 shares $6.38 million No Change4.1%9.1 $4.49 1/31/20231,420,000 shares $6.86 million -7.2%4.1%8.7 $4.83 1/15/20231,530,000 shares $6.35 million +1.3%4.5%10.3 $4.15 12/30/20221,510,000 shares $3.70 million -5.6%4.4%12.5 $2.45 12/15/20221,600,000 shares $3.92 million +1.3%4.7%12.3 $2.45 11/30/20221,580,000 shares $4.53 million -3.1%4.6%10.7 $2.87 11/15/20221,630,000 shares $5.22 million +4.5%4.7%10.2 $3.20 10/31/20221,560,000 shares $5.87 million +3.3%4.5%8 $3.76 10/15/20221,510,000 shares $4.32 million -3.2%4.4%7.3 $2.86 9/30/20221,560,000 shares $4.31 million -7.1%4.5%4.7 $2.76 9/15/20221,680,000 shares $6.89 million -6.2%4.9%4.2 $4.10 8/31/20221,790,000 shares $7.07 million -6.3%5.2%4 $3.95 8/15/20221,910,000 shares $8.16 million +6.1%5.6%3.7 $4.27The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. OLMA Short Interest - Frequently Asked Questions What is Olema Pharmaceuticals' current short interest? Short interest is the volume of Olema Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 8,100,000 shares of OLMA short. Learn More on Olema Pharmaceuticals' current short interest. What is a good short interest ratio for Olema Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OLMA shares currently have a short interest ratio of 10.0. Learn More on Olema Pharmaceuticals's short interest ratio. Which institutional investors are shorting Olema Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Olema Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Olema Pharmaceuticals' short interest increasing or decreasing? Olema Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 8,100,000 shares, an increase of 60.1% from the previous total of 5,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Olema Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Olema Pharmaceuticals: Astria Therapeutics, Inc. (11.37%), Mineralys Therapeutics, Inc. (4.82%), Nuvation Bio Inc. (2.10%), Lyell Immunopharma, Inc. (15.53%), Verve Therapeutics, Inc. (28.03%), CureVac (5.47%), Korro Bio, Inc. (2.31%), Phathom Pharmaceuticals, Inc. (39.95%), SIGA Technologies, Inc. (12.77%), Silence Therapeutics plc (0.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Olema Pharmaceuticals stock? Short selling OLMA is an investing strategy that aims to generate trading profit from Olema Pharmaceuticals as its price is falling. OLMA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Olema Pharmaceuticals? A short squeeze for Olema Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OLMA, which in turn drives the price of the stock up even further. How often is Olema Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OLMA, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ATXS Short Squeeze MLYS Short Squeeze NUVB Short Squeeze LYEL Short Squeeze VERV Short Squeeze CVAC Short Squeeze KRRO Short Squeeze PHAT Short Squeeze SIGA Short Squeeze SLN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OLMA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press